1. Home
  2. GOSS vs ZEUS Comparison

GOSS vs ZEUS Comparison

Compare GOSS & ZEUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOSS
  • ZEUS
  • Stock Information
  • Founded
  • GOSS 2015
  • ZEUS 1954
  • Country
  • GOSS United States
  • ZEUS United States
  • Employees
  • GOSS N/A
  • ZEUS N/A
  • Industry
  • GOSS Biotechnology: Pharmaceutical Preparations
  • ZEUS Metal Fabrications
  • Sector
  • GOSS Health Care
  • ZEUS Industrials
  • Exchange
  • GOSS Nasdaq
  • ZEUS Nasdaq
  • Market Cap
  • GOSS 347.8M
  • ZEUS 352.6M
  • IPO Year
  • GOSS 2019
  • ZEUS 1994
  • Fundamental
  • Price
  • GOSS $2.47
  • ZEUS $33.71
  • Analyst Decision
  • GOSS Strong Buy
  • ZEUS Buy
  • Analyst Count
  • GOSS 4
  • ZEUS 1
  • Target Price
  • GOSS $8.50
  • ZEUS $38.00
  • AVG Volume (30 Days)
  • GOSS 3.1M
  • ZEUS 55.6K
  • Earning Date
  • GOSS 08-05-2025
  • ZEUS 10-30-2025
  • Dividend Yield
  • GOSS N/A
  • ZEUS 1.90%
  • EPS Growth
  • GOSS N/A
  • ZEUS N/A
  • EPS
  • GOSS N/A
  • ZEUS 1.23
  • Revenue
  • GOSS $40,237,000.00
  • ZEUS $1,878,204,000.00
  • Revenue This Year
  • GOSS N/A
  • ZEUS $0.48
  • Revenue Next Year
  • GOSS $30.65
  • ZEUS $2.77
  • P/E Ratio
  • GOSS N/A
  • ZEUS $27.48
  • Revenue Growth
  • GOSS N/A
  • ZEUS N/A
  • 52 Week Low
  • GOSS $0.66
  • ZEUS $26.32
  • 52 Week High
  • GOSS $2.65
  • ZEUS $43.60
  • Technical
  • Relative Strength Index (RSI)
  • GOSS 68.08
  • ZEUS 58.07
  • Support Level
  • GOSS $2.38
  • ZEUS $33.15
  • Resistance Level
  • GOSS $2.65
  • ZEUS $34.07
  • Average True Range (ATR)
  • GOSS 0.15
  • ZEUS 0.81
  • MACD
  • GOSS 0.03
  • ZEUS 0.23
  • Stochastic Oscillator
  • GOSS 76.67
  • ZEUS 86.91

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About ZEUS Olympic Steel Inc.

Olympic Steel Inc provides metals processing and distribution services in the United States. The company operates in three reportable segments; specialty metals flat products, carbon flat products, and tubular and pipe products. It specializes in the processing and distribution of large volumes of carbon, aluminum, and stainless steel flat-rolled sheet, coils, plates, bars, and fabricated parts. The group serves various industries such as industrial machinery and equipment manufacturers, automobile manufacturers and suppliers, and transportation equipment manufacturers. The company generates majority of the revenue from carbon flat products.

Share on Social Networks: